Soligenix, Inc. Registration Statement Declared Effective
Ticker: SNGX · Form: EFFECT · Filed: Apr 3, 2026 · CIK: 0000812796
| Field | Detail |
|---|---|
| Company | Soligenix, Inc. (SNGX) |
| Form Type | EFFECT |
| Filed Date | Apr 3, 2026 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: registration-statement, effectiveness, sec-filing
Related Tickers: SOLG
TL;DR
SOLG registration statement effective 4/2/26. Ready to raise cash.
AI Summary
Soligenix, Inc. filed an EFFECT form on April 3, 2026, indicating the effectiveness of a registration statement. The effectiveness date was April 2, 2026. The filing is related to Act 33 and has file number 333-271049.
Why It Matters
This filing signifies that Soligenix, Inc.'s securities offering has met SEC requirements and can now proceed with its planned capital raise.
Risk Assessment
Risk Level: medium — Effectiveness of a registration statement is a procedural step, and the actual success of the offering and its impact on the company's stock price are subject to market conditions and investor sentiment.
Key Numbers
- 2026-04-02 — Effectiveness Date (The date the registration statement became effective.)
- 333-271049 — File Number (The SEC file number associated with this registration.)
Key Players & Entities
- Soligenix, Inc. (company) — Filer
- 0000812796 (company) — CIK number for Soligenix, Inc.
- 333-271049 (dollar_amount) — File number associated with the filing
- 2026-04-03 (date) — Acceptance date of the filing
- 2026-04-02 (date) — Effectiveness date of the registration statement
FAQ
What type of filing is this?
This is a Form EFFECT, which signifies a Notice of Effectiveness for a registration statement.
When did the registration statement become effective?
The registration statement became effective on April 2, 2026.
What is the CIK number for Soligenix, Inc.?
The CIK number for Soligenix, Inc. is 0000812796.
What is the SEC file number associated with this filing?
The SEC file number is 333-271049.
What is the primary business of Soligenix, Inc. according to the filing?
Soligenix, Inc. is in the Pharmaceutical Preparations industry (SIC 2834).
Filing Stats: 35 words · 1 min read · ~1 pages · Grade level 11.8 · Accepted 2026-04-03 00:15:04
Filing Documents
- primary_doc.html (EFFECT)
- primary_doc.xml (EFFECT) — 1KB
- 9999999995-26-001056.txt ( ) — 2KB
From the Filing
Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: April 2, 2026 Submission Type: POS AM CIK: Company Name: SOLIGENIX, INC. File Number: 333-271049